Cited by 164Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesCardiac Health and Mental Health

The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation

Open access
Groenveld, Hessel F., Crijns, Harry J.G.M., Van den Berg, Maarten P., Van Sonderen, Eric, Alings, A. Marco, Tijssen, Jan G.P., Hillege, Hans L., Tuininga, Ype S. +3 more·2011·Journal of the American College of Cardiology

Abstract

Objectives The aim of this study was to investigate the influence of rate control on quality of life (QOL).Background The RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) trial showed that lenient rate control is not inferior to strict rate control in terms of cardiovascular morbidity and mortality. The influence of stringency of rate control on QOL is unknown.Methods In RACE II, a total of 614 patients with permanent atrial fibrillation (AF) were randomized to lenient (resting heart rate [HR] <110 beats/min) or strict (resting HR <80 beats/min, HR during moderate exercise <110 beats/min) rate control. QOL was assessed in 437 patients using the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) questionnaire, AF severity scale, and Multidimensional Fatigue Inventory-20 (MFI-20) at baseline, 1 year, and end of study. QOL changes were related to patient characteristics.Results Median follow-up was 3 years. Mean age was 68 ± 8 years, and 66% were males. At the end of follow-up, all SF-36 subscales were comparable between both groups. The AF severity scale was similar at baseline and end of study. At baseline and at end of study there were no differences in the MFI-20 subscales between the 2 groups. Symptoms at baseline, younger age, and less severe underlying disease, rather than assigned therapy or heart rate, were associated with QOL improvements. Female sex and cardiovascular endpoints during the study were associated with worsening of QOL.Conclusions Stringency of heart rate control does not influence QOL. Instead, symptoms, sex, age, and severity of the underlying disease influence QOL. (Rate Control Efficacy in Permanent Atrial Fibrillation; NCT00392613).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2011.06.055

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the RACE II study, there was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), NYHA class, or hospitalizations.

    “There was no difference in a composite of clinical events (14.9% in the strict rate control group, 12.9% in the lenient group), 560 NYHA class, or hospitalizations.560, 561”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Groenveld, H. F., Crijns, H. J. G. M., Van den Berg, M. P., Van Sonderen, E., Alings, A. M., Tijssen, J. G. P., Hillege, H. L., Tuininga, Y. S., Van Veldhuisen, D. J., Ranchor, A. V., & Van Gelder, I. C.
Affiliations
  • University Medical Center Groningen (NL)
  • Maastricht University Medical Centre (NL)
  • University of Amsterdam (NL)
  • Deventer Ziekenhuis (NL)
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2011-10
Volume
58
Issue
17
Pages
1795-1803
ISSN
0735-1097 (ISSN-L)
OpenAlex
W1531214291
Cited by
164
References
39
Citations by year
2026: 3 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 12 · 2021: 13 · 2020: 14 · 2019: 6 · 2018: 5 · 2017: 15 · 2016: 14 · 2015: 9 · 2014: 16 · 2013: 12 · 2012: 14
FWCI
9.90
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • Pure Amsterdam UMC (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (acceptedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Netherlands Heart Foundation (2003B118)
  • Medtronic
  • Biotronik
  • St. Jude Medical
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
permanent atrial fibrillation, rate control, quality of life, resting heart rate, fatigue, SF-36, Multidimensional Fatigue Inventory, sex differences, age
MeSH terms
Adrenergic beta-Antagonists, Aged, Atrial Fibrillation, Calcium Channel Blockers, Cardiovascular Agents, Digoxin, Female, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Quality of Life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review